
CBC Group
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
CBC Group is a healthcare-dedicated investment firm that creates value and integrates global resources.
Investor Profile
CBC Group has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Therapeutics, Oncology.
Stage Focus
- Series B (67%)
- Series A (33%)
Country Focus
- China (67%)
- United States (33%)
Industry Focus
- Biotechnology
- Therapeutics
- Oncology
- Health Care
- Pharmaceutical
- Manufacturing
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does CBC Group frequently co-invest with?
What are some of recent deals done by CBC Group?
Find More Investors Like CBC Group
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








